US approves first drug for severe form of fatty liver disease

The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.

Madrigal Pharmaceuticals’ Rezdiffra was shown to improve liver scarring in a clinical trial…